Weston A - Search Results

1

True extended haplotypes of p53: indicators of breast cancer risk.

Weston A, Wolff MS, Morabia A. Weston A, et al. Cancer Genet Cytogenet. 1998 Apr 15;102(2):153-4. doi: 10.1016/s0165-4608(97)00349-x. Cancer Genet Cytogenet. 1998. PMID: 9546072 No abstract available.

2

p53 haplotype determination in breast cancer.

Weston A, Pan CF, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, Bleiweiss IJ, Brower ST, Senie RT, Wolff MS. Weston A, et al. Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):105-12. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9037561

3

Breast cancer risk and environmental exposures.

Wolff MS, Weston A. Wolff MS, et al. Among authors: weston a. Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):891-6. doi: 10.1289/ehp.97105s4891. Environ Health Perspect. 1997. PMID: 9255576 Free PMC article. Review.

4

Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States.

Keshava C, McCanlies EC, Keshava N, Wolff MS, Weston A. Keshava C, et al. Among authors: weston a. Cancer Lett. 2001 Nov 8;173(1):37-41. doi: 10.1016/s0304-3835(01)00671-1. Cancer Lett. 2001. PMID: 11578807

5

Waf-1 (p21) and p53 polymorphisms in breast cancer.

Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A. Keshava C, et al. Among authors: weston a. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):127-30. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815410

6

CYP17 genotype and breast cancer risk.

Weston A, Pan CF, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS. Weston A, et al. Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):941-4. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9796640

7

Organochlorine exposures and breast cancer risk in New York City women.

Wolff MS, Berkowitz GS, Brower S, Senie R, Bleiweiss IJ, Tartter P, Pace B, Roy N, Wallenstein S, Weston A. Wolff MS, et al. Among authors: weston a. Environ Res. 2000 Oct;84(2):151-61. doi: 10.1006/enrs.2000.4075. Environ Res. 2000. PMID: 11068929

8

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.

Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, Eng CM. Fodor FH, et al. Among authors: weston a. Am J Hum Genet. 1998 Jul;63(1):45-51. doi: 10.1086/301903. Am J Hum Genet. 1998. PMID: 9634504 Free PMC article.

9

Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Weston A, Godbold JH. Weston A, et al. Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):919-26. doi: 10.1289/ehp.97105s4919. Environ Health Perspect. 1997. PMID: 9255581 Free PMC article.

10

Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Weston A, Caporaso NE, Perrin LS, Sugimura H, Tamai S, Krontiris TG, Trump BF, Hoover RN, Harris CC. Weston A, et al. Environ Health Perspect. 1992 Nov;98:61-7. doi: 10.1289/ehp.929861. Environ Health Perspect. 1992. PMID: 1486864 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page